Abeona Therapeutics Inc.ABEONASDAQ
Loading
Year-over-year net income growth rate
Percentile
P5
Near historical low
vs 3Y Ago
-11.9x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -296.43% |
| Q3 2025 | -104.74% |
| Q2 2025 | 1004.76% |
| Q1 2025 | -29.44% |
| Q4 2024 | 69.30% |
| Q3 2024 | -508.71% |
| Q2 2024 | 123.45% |
| Q1 2024 | -90.33% |
| Q4 2023 | -40.17% |
| Q3 2023 | 28.93% |
| Q2 2023 | -82.87% |
| Q1 2023 | -27.89% |
| Q4 2022 | 24.92% |
| Q3 2022 | -131.49% |
| Q2 2022 | 81.41% |
| Q1 2022 | 52.78% |
| Q4 2021 | -562.73% |
| Q3 2021 | 53.68% |
| Q2 2021 | 4.97% |
| Q1 2021 | -1.10% |
| Q4 2020 | -118.71% |
| Q3 2020 | 44.37% |
| Q2 2020 | 72.99% |
| Q1 2020 | -193.10% |
| Q4 2019 | 5.42% |
| Q3 2019 | 27.39% |
| Q2 2019 | -28.94% |
| Q1 2019 | -6.16% |
| Q4 2018 | -6.46% |
| Q3 2018 | -40.33% |
| Q2 2018 | -38.25% |
| Q1 2018 | -0.15% |
| Q4 2017 | -58.15% |
| Q3 2017 | 35.46% |
| Q2 2017 | -57.79% |
| Q1 2017 | 25.06% |
| Q4 2016 | -166.84% |
| Q3 2016 | 60.85% |
| Q2 2016 | -20.91% |
| Q1 2016 | -136.92% |